FDA Inspection 1083116 — Sircle Laboratories, L.L.C.

Sircle Laboratories, L.L.C. — FEI 3011772828

The FDA completed an inspection of Sircle Laboratories, L.L.C. on March 19, 2019 in Madison, MS. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 19, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Madison, MS (United States)

Citations

IDCFRDescription
107921 CFR 211.22(a)Contract drug products--lack of responsibility
149521 CFR 211.122(a)Written procedures describing in detail
438621 CFR 211.198(b)Written complaint record to be maintained at facility